Catalog Number CDS0602-XTR |
Device Problem
Incomplete Coaptation (2507)
|
Patient Problems
Cardiac Enzyme Elevation (1838); Mitral Regurgitation (1964); Heart Failure (2206)
|
Event Date 04/23/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.On (b)(6) 2019: creatine kinase (ck)=24 iu/l, normal upper limit 195.On (b)(6) 2019: troponin i=50.3 ng/ml, upper reference limit 14.The clip remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
|
Event Description
|
This report is filed as the clip detached from the posterior leaflet and the patient was hospitalized for worsening mitral regurgitation and congestive heart failure.It was reported that on (b)(6) 2019, the patient presented with degenerative mitral regurgitation (mr) grade 4+, with an anterior leaflet 2 (a2) prolapse, primary jet a2p2, and mitral annular calcification.Reportedly, the patient possibly had friable leaflets.One mitraclip was implanted at the a2p2 without a device deficiency.The mr was reduced to grade 2+ and the patient was discharged from the hospital.On (b)(6) 2019, per echocardiography,the mr had increased to grade 4+.The clip had detached from the posterior leaflet, while remaining attached to the anterior leaflet (single leaflet device attachment-slda).On (b)(6) 2019, the patient was hospitalized for worsening congestive heart failure.Elevated troponin was observed.As treatment, the furosemide medication was increased and another mitraclip procedure was performed on (b)(6) 2019, with implantation of a second mitraclip.No additional information was provided regarding this issue.
|
|
Event Description
|
Subsequent to the previous report, additional information received: the worsened heart failure resolved and the patient was discharged from hospital on (b)(6) 2019.
|
|
Manufacturer Narrative
|
Internal file number - (b)(4).The device was not returned for analysis.A review of the lot history records identified no manufacturing nonconformities issued to the reported lots that would have contributed to the reported event.Additionally, a review of the complaint history revealed no indication of a lot specific product issue.It should be noted that the reported patient effect of worsening mitral regurgitation (mr) and heart failure, as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.All available information was investigated and a definitive cause for the reported single leaflet device attachment (slda), enzyme elevation, recurrent mr and heart failure could not be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|
|